Posts Tagged ‘Aducanuma’
Biogen Reverses Course, Asks FDA To Approve Failed Alzheimer’s Drug
Biogen, a United States drug manufacturer, has asked the Food and Drug Administration (FDA), to approve their Alzheimer’s drug, Aducanumab. Their request is highly unusual, as it’s the same drug they suspended testing just seven months ago because it was ineffective in Phase-2 clinical trials. The Biogen announcement, shocked the scientific community and the…
Read More